Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Aerosolizable plasmid DNA dry powders engineered by thin-film freezing

Haiyue Xu, Chaeho Moon, Sawittree Sahakijpijarn, Huy M. Dao, Riyad F. Alzhrani, Jie-liang Wang, View ORCID ProfileRobert O. Williams III, Zhengrong Cui
doi: https://doi.org/10.1101/2022.10.03.510625
Haiyue Xu
1Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX, 78712, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chaeho Moon
1Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX, 78712, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sawittree Sahakijpijarn
2TFF Pharmaceuticals, Inc. Austin, TX, 78753, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Huy M. Dao
1Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX, 78712, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Riyad F. Alzhrani
1Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX, 78712, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jie-liang Wang
1Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX, 78712, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert O. Williams III
1Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX, 78712, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Robert O. Williams III
  • For correspondence: bill.williams@austin.utexas.edu Zhengrong.cui@austin.utexas.edu
Zhengrong Cui
1Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX, 78712, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: bill.williams@austin.utexas.edu Zhengrong.cui@austin.utexas.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Preview PDF
Loading

ABSTRACT

This study was designed to test the feasibility of using thin-film freezing (TFF) to prepare aerosolizable dry powders of plasmid DNA (pDNA) for pulmonary delivery. Dry powders of pDNA formulated with mannitol/leucine (70/30, w/w) at various of drug loadings, solid contents, and solvents were prepared using TFF, their aerosol properties (i.e., mass median aerodynamic diameter (MMAD) and fine particle fraction (FPF)) determined, and selected powders were used for further characterization. Of the nine dry powders prepared, their MMAD values were about 1-2 mm, with FPF values (delivered) of 40-80%. The aerosol properties of the powders were inversely correlated with the pDNA loading and the solid content in the pDNA solution before thin-film freezing. Powders prepared with Tris-EDTA (TE) buffer or cosolvents (i.e., 1,4 dioxane or t-butanol in water), instead of water, showed slightly reduced aerosol properties. Ultimately, powders prepared with pDNA loading at 5% (w/w), 0.25% of solid content, with or without TE were selected for further characterization due to their overall good aerosol performance. The pDNA powders exhibited a porous matrix, crystalline structure, with a moisture content of <2% (w/w). Agarose gel electrophoresis confirmed the chemical integrity of the pDNA after it was subjected to TFF and after the TFF powder was actuated. A cell transfection study confirmed the activity of the pDNA after it was subjected to TFF. In conclusion, it is feasible to use TFF to produce aerosolizable pDNA dry powder for pulmonary delivery, while preserving the integrity and activity of the pDNA.

Competing Interest Statement

Cui reports a relationship with TFF Pharmaceuticals, Inc. that includes equity or stocks and research funding. Williams reports a relationship with TFF Pharmaceuticals, Inc. that includes consulting or advisory, equity or stocks, and research funding. Xu and Moon report a relationship with TFF Pharmaceuticals, Inc. that includes: consulting or advisory. Financial conflict of interest management plans are available at UT Austin.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted October 07, 2022.
Download PDF
Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Aerosolizable plasmid DNA dry powders engineered by thin-film freezing
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Aerosolizable plasmid DNA dry powders engineered by thin-film freezing
Haiyue Xu, Chaeho Moon, Sawittree Sahakijpijarn, Huy M. Dao, Riyad F. Alzhrani, Jie-liang Wang, Robert O. Williams III, Zhengrong Cui
bioRxiv 2022.10.03.510625; doi: https://doi.org/10.1101/2022.10.03.510625
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Aerosolizable plasmid DNA dry powders engineered by thin-film freezing
Haiyue Xu, Chaeho Moon, Sawittree Sahakijpijarn, Huy M. Dao, Riyad F. Alzhrani, Jie-liang Wang, Robert O. Williams III, Zhengrong Cui
bioRxiv 2022.10.03.510625; doi: https://doi.org/10.1101/2022.10.03.510625

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Pharmacology and Toxicology
Subject Areas
All Articles
  • Animal Behavior and Cognition (4095)
  • Biochemistry (8784)
  • Bioengineering (6490)
  • Bioinformatics (23378)
  • Biophysics (11763)
  • Cancer Biology (9165)
  • Cell Biology (13269)
  • Clinical Trials (138)
  • Developmental Biology (7420)
  • Ecology (11380)
  • Epidemiology (2066)
  • Evolutionary Biology (15111)
  • Genetics (10408)
  • Genomics (14017)
  • Immunology (9135)
  • Microbiology (22087)
  • Molecular Biology (8792)
  • Neuroscience (47419)
  • Paleontology (350)
  • Pathology (1422)
  • Pharmacology and Toxicology (2483)
  • Physiology (3710)
  • Plant Biology (8060)
  • Scientific Communication and Education (1433)
  • Synthetic Biology (2213)
  • Systems Biology (6020)
  • Zoology (1251)